313 related articles for article (PubMed ID: 30266571)
1. Cellular and molecular mechanisms of glioblastoma malignancy: Implications in resistance and therapeutic strategies.
Balça-Silva J; Matias D; Carmo AD; Sarmento-Ribeiro AB; Lopes MC; Moura-Neto V
Semin Cancer Biol; 2019 Oct; 58():130-141. PubMed ID: 30266571
[TBL] [Abstract][Full Text] [Related]
2. Chemoresistance in high-grade gliomas: relevance of adenosine signalling in stem-like cells of glioblastoma multiforme.
Garrido W; Rocha JD; Jaramillo C; Fernandez K; Oyarzun C; San Martin R; Quezada C
Curr Drug Targets; 2014; 15(10):931-42. PubMed ID: 25174341
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic strategies targeting glioblastoma stem cells.
Carrasco-Garcia E; Sampron N; Aldaz P; Arrizabalaga O; Villanua J; Barrena C; Ruiz I; Arrazola M; Lawrie C; Matheu A
Recent Pat Anticancer Drug Discov; 2013 Sep; 8(3):216-27. PubMed ID: 23607282
[TBL] [Abstract][Full Text] [Related]
4. Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain.
Agarwal S; Sane R; Oberoi R; Ohlfest JR; Elmquist WF
Expert Rev Mol Med; 2011 May; 13():e17. PubMed ID: 21676290
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances on Glioblastoma Multiforme and Nano-drug Carriers: A Review.
Liao W; Fan S; Zheng Y; Liao S; Xiong Y; Li Y; Liu J
Curr Med Chem; 2019; 26(31):5862-5874. PubMed ID: 29768997
[TBL] [Abstract][Full Text] [Related]
6. Validation of Thiosemicarbazone Compounds as P-Glycoprotein Inhibitors in Human Primary Brain-Blood Barrier and Glioblastoma Stem Cells.
Salaroglio IC; Abate C; Rolando B; Battaglia L; Gazzano E; Colombino E; Costamagna C; Annovazzi L; Mellai M; Berardi F; Capucchio MT; Schiffer D; Riganti C
Mol Pharm; 2019 Aug; 16(8):3361-3373. PubMed ID: 31265310
[TBL] [Abstract][Full Text] [Related]
7. Drug Repurposing for Glioblastoma and Current Advances in Drug Delivery-A Comprehensive Review of the Literature.
Alomari S; Zhang I; Hernandez A; Kraft CY; Raj D; Kedda J; Tyler B
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944514
[TBL] [Abstract][Full Text] [Related]
8. Blocking distinct interactions between Glioblastoma cells and their tissue microenvironment: A novel multi-targeted therapeutic approach.
Mettang M; Meyer-Pannwitt V; Karpel-Massler G; Zhou S; Carragher NO; Föhr KJ; Baumann B; Nonnenmacher L; Enzenmüller S; Dahlhaus M; Siegelin MD; Stroh S; Mertens D; Fischer-Posovszky P; Schneider EM; Halatsch ME; Debatin KM; Westhoff MA
Sci Rep; 2018 Apr; 8(1):5527. PubMed ID: 29615749
[TBL] [Abstract][Full Text] [Related]
9. STAT3 as a Therapeutic Target for Glioblastoma.
Liu Y; Li C; Lin J
Anticancer Agents Med Chem; 2010 Sep; 10(7):512-9. PubMed ID: 20879983
[TBL] [Abstract][Full Text] [Related]
10. Novel delivery strategies for glioblastoma.
Zhou J; Atsina KB; Himes BT; Strohbehn GW; Saltzman WM
Cancer J; 2012; 18(1):89-99. PubMed ID: 22290262
[TBL] [Abstract][Full Text] [Related]
11. Overcoming brain barriers through surface-functionalized liposomes for glioblastoma therapy; current status, challenges and future perspective.
Dong C; Yu X; Jin K; Qian J
Nanomedicine (Lond); 2023 Dec; 18(30):2161-2184. PubMed ID: 38180008
[TBL] [Abstract][Full Text] [Related]
12. Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier.
Da Ros M; De Gregorio V; Iorio AL; Giunti L; Guidi M; de Martino M; Genitori L; Sardi I
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30248992
[TBL] [Abstract][Full Text] [Related]
13. Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response.
Hombach-Klonisch S; Mehrpour M; Shojaei S; Harlos C; Pitz M; Hamai A; Siemianowicz K; Likus W; Wiechec E; Toyota BD; Hoshyar R; Seyfoori A; Sepehri Z; Ande SR; Khadem F; Akbari M; Gorman AM; Samali A; Klonisch T; Ghavami S
Pharmacol Ther; 2018 Apr; 184():13-41. PubMed ID: 29080702
[TBL] [Abstract][Full Text] [Related]
14. The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals.
Wang Y; Ying X; Xu H; Yan H; Li X; Tang H
Int J Nanomedicine; 2017; 12():1369-1384. PubMed ID: 28260885
[TBL] [Abstract][Full Text] [Related]
15. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
16. Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine.
Kim SS; Harford JB; Pirollo KF; Chang EH
Biochem Biophys Res Commun; 2015 Dec; 468(3):485-9. PubMed ID: 26116770
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy resistance of glioblastoma stem cells.
Eramo A; Ricci-Vitiani L; Zeuner A; Pallini R; Lotti F; Sette G; Pilozzi E; Larocca LM; Peschle C; De Maria R
Cell Death Differ; 2006 Jul; 13(7):1238-41. PubMed ID: 16456578
[No Abstract] [Full Text] [Related]
18. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
Karim R; Palazzo C; Evrard B; Piel G
J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
[TBL] [Abstract][Full Text] [Related]
19. The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence.
Auffinger B; Spencer D; Pytel P; Ahmed AU; Lesniak MS
Expert Rev Neurother; 2015; 15(7):741-52. PubMed ID: 26027432
[TBL] [Abstract][Full Text] [Related]
20. Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide.
Kim SS; Harford JB; Moghe M; Rait A; Pirollo KF; Chang EH
Nucleic Acids Res; 2018 Feb; 46(3):1424-1440. PubMed ID: 29202181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
